JPRN-C000000307
Completed
Phase 3
Randomized phase III trial of postoperative whole brain radiation therapy compared with salvage stereotactic radiosurgery in patients with one to four brain metastasis: Japan Clinical Oncology Group Study (JCOG 0504) - Phase III trial of postoperative WBRT vs. salvage SRT for one to four brain metastasis. JCOG0504
Japan Clinical Oncology Group(JCOG)0 sites270 target enrollmentJanuary 18, 2006
Conditionsbrain neoplasms/secondary
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- brain neoplasms/secondary
- Sponsor
- Japan Clinical Oncology Group(JCOG)
- Enrollment
- 270
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) synchronous or metachronous (within 5 years) malignancy other than carcinoma in situ or mucosal cancer (2\) pregnant or breast\-feeding women (3\) severe mental disease (4\) allergic to gadolinium contained contrast agents
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neckCTIS2024-513206-65-00Groupe Oncologie Radiotherapie Tete Cou674
Active, not recruiting
Phase 1
Randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neckSquamous cell carcinoma treated by primary surgeryStage III, stage IV (American Joint Committee on Cancer 7th edition)Oral cavity, oropharynx, hypopharynx or larynxMedDRA version: 21.0Level: PTClassification code 10060121Term: Squamous cell carcinoma of head and neckSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2017-004936-13-PLGORTEC680
Active, not recruiting
Phase 1
Randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neckEUCTR2017-004936-13-GRGORTEC680
Active, not recruiting
Phase 1
randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neckEUCTR2017-004936-13-BEGORTEC680
Completed
Phase 3
Randomized phase III trial of surgery followed by mFOLFOX6 as adjuvant chemotherapy versus peri-operative mFOLFOX6 plus cetuximab for KRAS wild type resectable liver metastases of colorectal cancerResectable colorectal liver metastasesJPRN-UMIN000007787Hepato-biliary-pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo500